1. Home
  2. NAN vs SIGA Comparison

NAN vs SIGA Comparison

Compare NAN & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen New York Quality Municipal Income Fund

NAN

Nuveen New York Quality Municipal Income Fund

HOLD

Current Price

$11.39

Market Cap

356.7M

Sector

Finance

ML Signal

HOLD

Logo SIGA Technologies Inc.

SIGA

SIGA Technologies Inc.

HOLD

Current Price

$5.25

Market Cap

401.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAN
SIGA
Founded
1999
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
356.7M
401.0M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
NAN
SIGA
Price
$11.39
$5.25
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
79.7K
475.0K
Earning Date
01-01-0001
06-15-2026
Dividend Yield
4.37%
10.97%
EPS Growth
N/A
N/A
EPS
N/A
0.32
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$132.36
P/E Ratio
N/A
$17.09
Revenue Growth
N/A
N/A
52 Week Low
$10.69
$4.95
52 Week High
$11.67
$9.62

Technical Indicators

Market Signals
Indicator
NAN
SIGA
Relative Strength Index (RSI) 40.45 25.09
Support Level $11.37 $5.21
Resistance Level $11.50 $6.98
Average True Range (ATR) 0.08 0.26
MACD -0.02 -0.13
Stochastic Oscillator 17.19 5.31

Price Performance

Historical Comparison
NAN
SIGA

About NAN Nuveen New York Quality Municipal Income Fund

Nuveen New York Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About SIGA SIGA Technologies Inc.

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.

Share on Social Networks: